Arcutis Biotherapeutics (ARQT) Interest & Investment Income (2019 - 2026)
Arcutis Biotherapeutics (ARQT) posted quarterly Interest & Investment Income of -$351000.0 for Q1 2026, down 113.84% year-over-year from $2.5 million in Q1 2025, and down 735.71% quarter-over-quarter from -$42000.0 in Q4 2025.
Powered by 
Analysis
Arcutis Biotherapeutics (ARQT) Interest & Investment Income (2019 - 2026) Analysis & Trends
Arcutis Biotherapeutics' Interest & Investment Income history runs 8 years deep, the most recent figure standing at -$351000.0 for Q1 2026.
- In Q1 2026, Interest & Investment Income fell 113.84% year-over-year to -$351000.0; the TTM figure through Mar 2026 stood at -$420000.0 (down 114.62% YoY), while the FY2025 annual figure was -$206000.0, down 194.06% from the prior year.
- Interest & Investment Income for Q1 2026 stood at -$351000.0, down from -$42000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $2.5 million in Q1 2025, with the low at -$765000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is -$42000.0 (2025), against an average of $158294.1.
- The sharpest annual moves came in 2022 and 2025: Interest & Investment Income plunged 2011.11% in 2022, then soared 2287.07% in 2025.
- Arcutis Biotherapeutics' Interest & Investment Income stood at $510000.0 in 2022, then slumped by 66.86% to $169000.0 in 2023, then slumped by 282.84% to -$309000.0 in 2024, then soared by 86.41% to -$42000.0 in 2025, then sank by 735.71% to -$351000.0 in 2026.
- Business Quant data shows ARQT's Interest & Investment Income at -$351000.0 in Q1 2026, -$42000.0 in Q4 2025, and $68000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Arcutis Biotherapeutics | 3.12 Bn | 2.88 Bn | 118.92 Mn | 2.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.28 Mn |
| Mar 31, 2026 | -351,000.00 |
| Dec 31, 2025 | 9.06 Mn |
| Sep 30, 2025 | 68,000.00 |
| Jun 30, 2025 | 2.08 Mn |
| Mar 31, 2025 | -137,000.00 |
| Dec 31, 2024 | 15.60 Mn |
| Sep 30, 2024 | 771,000.00 |
| Jun 30, 2024 | -127,000.00 |
| Mar 31, 2024 | -116,000.00 |
| Dec 31, 2023 | 11.50 Mn |
| Sep 30, 2023 | 165,000.00 |
| Jun 30, 2023 | 128,000.00 |
| Mar 31, 2023 | 724,000.00 |
| Dec 31, 2022 | 510,000.00 |
| Sep 30, 2022 | -344,000.00 |
| Jun 30, 2022 | -232,000.00 |
| Mar 31, 2022 | -765,000.00 |
| Dec 31, 2021 | -237,000.00 |
| Sep 30, 2021 | 18,000.00 |